The dose dependence of L-ascorbic acid (AsA) copromotion of urinary bladder carcinogenesis with continuous concomitant administration of NaHCO 3 was investigated. In the first experiment, 83 male F344 rats were all given 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) for 4 wk and then divided into 5 groups, which received basal diet (Oriental MF) containing AsA at 0, 1, 2, 3.5, or 5% plus 1.5% NaHCO 3 for 32 wk. Relative urinary bladder weights in the 5% AsA group were significantly increased as compared to the 0 or 1% group values due to the development of tumors. Both the incidence and number of microscopic urinary bladder lesions (tumors and preneoplastic lesions) showed dose-dependent increases. Furthermore, the sizes of the urinary bladder tumors (carcinomas and papillomas) were significantly increased with the highest dose. 5-bromo-2'-deoxyuridine labeling indices showed slightly increased proliferation in preneoplastic lesions of the urinary bladder epithelium with 5% AsA treatment. In a separate experiment, scanning electron microscopic observation revealed that administration of 5% AsA plus 1.5% NaHCO 3 for 8 wk, without BBN, altered the urinary bladder surface. Elevation of urinary bladder epithelium AsA content, as well as urinary AsA, was also noted. Ornithine decarboxylase (ODC) activity and ODC messenger RNA levels in urinary bladder epithelium of rats treated with 1.5% NaHCO 3 plus 5% AsA for 8 wk showed no statistically significant differences as compared to the control group. The results indicate that AsA amplifies the rat urinary bladder carcinogenesis promotion activity of NaHCO 3 and that its intensity of action depends on the dose, particularly at high dose.
INTRODUCTION
The concept of two-stage chemical carcinogenesis is now widely accepted, and experiments based on this understanding have been undertaken by many investigators since Berenblum and Shubikz first demonstrated its validity for mouse skin carcinogenesis (1) . Many environmental substances have thereby been identified that possess promoting activity for rat urinary bladder carcinogenesis (6, 16, 29, 31, 47) . Fukushima et al and others earlier reported that elevated urinary pH and sodium ion concentration significantly promoted development of neoplastic lesions in the rat urinary bladder (14, 15, 17, 19, 21-24, 35, 45) with the intensity of action depending on the dose of NaHC03 (15) . In a series of studies, it was revealed that L-ascorbic acid (AsA),3 well known as a factor that influences cancer (3) , could amplify the promoting activity of sodium salts, though itself not exerting any promoting potential (15, 19, 21) .
The present study was conducted to determine whether there might be a dose threshold for AsA with a constant level of NaHC03 (1.5% in diet) in terms of copromotion of urinary bladder tumor development in male F344 rats. In addition to quantitation of lesions, we estimated the effects of AsA on urinary bladder epithelial cell prolif-eration both biochemically, by measurement of ornithine decarboxylase (ODC) activity and mRNA levels, and morphologically, by assessing 5-bromo-2'-deoxyuridine (BrdU) incorporation and scanning electron microscope (SEM) observation.
MATERIALS AND METHODS
Animals. A total of 150 6-wk-old male F344 rats (Charles River Japan, Inc., Atsugi, Japan) was used. The rats were housed 5 per plastic cage with wood chips for bedding in an animal room with a 12-hr light, 12-hr dark cycle at 22 ± 2°C and 44 ~-5% relative humidity.
Chemicals. N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) was obtained from Tokyo Kasei Co., Osaka, Japan. The AsA and NaHC03 (Wako Pure Chemical Ind., Osaka, Japan) were food additive grade. Experiment 1. Eighty-three rats were randomly divided into 5 groups of 19 (Group 1) or 16 (Groups 2-5) rats each. All groups were given drinking water with 0.05% BBN for the first 4 wk. Three days after cessation of BBN treatment, Groups 1 to 5 were given powdered basal diet (Oriental MF; Oriental Yeast Co., Tokyo, Japan) containing 1.5% NaHC03 plus AsA at concentrations of 0 (control group), 1, 2, 3.5, or 5%, respectively, for 32 wk. The total duration of the experiment was 36 wk and 3 days.
Urine examination was performed at wk 12, 24, and 36 with samples gained by forced urination in the morning (8:00-9:00 am). The pH of fresh urine was measured (Horiba pH meter, model F-15, Kyoto, Japan), and the samples were then analyzed for sodium, potassium, and chloride level (Hitachi-710 electrolyte analyzer, Tokyo, Ja- All rats were treated with a single ip injection of BrdU (Sigma Chemical Co., St. Louis, MO) at the dose of 50 mg/kg body weight 1 hr before sacrifice under ether anesthesia on the fourth day of week 37, when their urinary bladders, livers, and kidneys were immediately removed. Urinary bladders were inflated by intraluminal injection of 10% phosphate-buffered formalin solution. After 48 hr fixation, the bladders were divided sagittally, weighed, and each half was cut into four strips for histological examination. For quantitative analysis, urinary bladder lesions were counted under the light microscope, the total length of the basement membrane and the areas of tumors being measured with the aid of a color video-image processor (VIP-21C, Olympus-Ikegami Tsushin Co., Tokyo, Japan), and the number of lesions per 10 cm of basement membrane was calculated.
Epithelial cells incorporating BrdU were visualized in histological sections by the avidin-biotin-peroxidase complex immunohistochemical method applying anti-BrdU monoclonal antibody (Dako Japan Co., Ltd., Kyoto, Japan). Numbers of labeled cells in epithelial hyperplasias were counted under the light microscope and labeling indices were expressed as percentage values. Experiment 2. Thirty-two male F344 rats were divided into 2 groups. They were administered powdered basal diet (Oriental MF) with (Group 1, 16 rats) or without (Group 2, 16 rats) 1.5% NaHC03 plus 5% AsA for 8 wk without BBN pretreatment. The rats were sacrificed under anesthesia at the beginning of week 9, and the mucosa of each bladder was stripped off from the submucosa using a microcover glass (Matsunami Glass Ind., Ltd., Saka, Japan). One sample was composed of pooled mucosa from 3 or 4 rats. After suspension in 0.5 ml of 50 mM Tris (pH 7.5) containing 0.25 M sucrose, the tissues were disrupted by sonication for 30 sec (Sonifer Ultrasonics, Inc., New York) and centrifuged at 100,000 g for 30 min. The supernatants were assayed for ODC activity by measurement of the amount of radioactive putrescine produced from [5-14C]ornithine (35) . Experiment 3. Fifteen male F344 rats were divided into 2 groups. They were administered powdered basal diet (Oriental MF) with (Group 1, 10 rats) or without (Group 2, 5 rats) 1.5% NaHC03 plus 5% AsA for 8 wk. Samples were collected as described in Experiment 2.
RNA was extracted from fresh samples by the acid guanidinium thiocyanate-phenol chloroform method (5) . Part of ODC and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs were obtained by polymerase chain reaction (PCR) amplification using rat liver cDNA as a template. The primers 5'-CTGAAATACA-GTTGGTGCAG-3' and 5'-CTGGCAACTTTCAT-CAACTC-3' were used for amplifying a 154 bp ODC cDNA. The primers 5'-CGAGATCCATCTTCCAGGAG-3' and 5'-TAAGCAGTTGGTGGTGCAGG-3' were used for amplifying a 248 bp GAPDH cDNA. These PCR products were cloned into the Srfl site of PCR-Script SK(+) plasmid vector (Stratagene, La Jolla, CA, USA) and used as templates for production of RNA probes using the RNase protection assay. The antisense RNA probes for ODC and GAPDH mRNA were synthesized according to the manufacturer's instructions (MAXIscript Experiment 4. Twenty male F344 rats were divided into 4 groups, all given 1.5% NaHC03, and administered AsA at levels of 0, 1, 3.5, or 5%, respectively, for 8 wk. At the end of this treatment period, 3 rats in each group were randomly selected and sacrificed. Minced half bladders were placed in 1.0 ml of ice-cold 6% trichloroacetic acid, homogenized in ice water, and centrifuged at 3,000 rpm for 10 min. Aliquots of the resultant supernatants were assayed for AsA by the 2,4-dinitro-phenylhydrazine colorimetric method (42) . The bladders of the remaining 2 rats in each group were inflated with 2% glutaraldehyde in 0.1 M phosphate buffer and divided in half longitudinally. One half was used for SEM (Hitachi S-450, Hitachi Co., Ltd., Tokyo, Japan) using the procedures detailed previously (12) , and the other half was processed for light microscopic examination. Statistical analysis. Differences in incidences of lesions were analyzed for statistical significance by the one-sided Fisher's exact probability test. Other data were analyzed using the Student's t-test.
RESULTS

Experiment 1
One rat in Group 1 (5% AsA) died at week 33 and was not included in the effective numbers. A tendency for soft feces was observed in line with the increase in intake of AsA, but symptoms of severe toxicity were not noted at any time during the experiment. Data for final body and relative urinary bladder weights and food consumption are summarized in Table I . Final body weights of Groups 1-4 were significantly lower than in the AsAfree Group 5 (p < 0.05). Food consumption and BBN intake (data not shown) were essentially equal for all groups. At week 36, hematuria was frequently observed in rats of all groups, especially in the AsA high-dose groups.
Macroscopically, urinary bladder tumors of rats in Group 1 were larger in size and more numerous than in the AsA-free or low-dose groups. The relative urinary bladder weights were increased in parallel with the concentration of AsA (Table I) . A statistically significant increase of urinary bladder weights in Group 1 was recognized as compared with Groups 4 or 5.
Histological findings for urinary bladder epithelial lesions are listed in Table II . The numbers of urinary bladder tumors (including carcinomas and papillomas) were increased in a loose AsA dose-dependent manner and showed significant increase in the 5% AsA group, along with increased incidences and numbers of carcinomas.
The numbers of putative preneoplastic lesions and papillary or nodular (PN) hyperplasias (18) were also significantly increased in the 2, 3.5, and 5% groups with an AsA dose dependence. The correlation between the area of tumors and the urinary AsA concentration is illustrated in Fig. 1 , with larger sized lesions accompanying higher urinary AsA concentrations. With 5% AsA, the tumor area was significantly increased as compared to the 1 % AsA dose. Data for urinary pH and electrolyte concentrations at week 36 are summarized in Table III . The urinary pH was significantly decreased with the 2 highest AsA doses, but values for all groups were relatively alkaline, as compared to background data for control rats, due to the NaHC03. Electrolytes such as sodium, potassium, and chloride ions showed no consistent pattern of differences among the groups, although the sodium ion concentration was increased in all groups as compared to our background data. Urinary analysis values at the other times investigated were essentially similar to those at week 36.
BrdU labeling indices of hyperplasias of the urinary bladder are shown in Table IV . Generally, the higher the AsA dose, the greater the increase in BrdU incorporation observed.
Experiment 2
Data for the activity of ODC in the urinary bladder mucosa of animals given 1.5% NaHC03 and 5% AsA for 8 wk are shown in Table V . No significant differences could be detected and considerable scatter was evident within the groups.
Experiment 3
ODC mRNA was found to be clearly present in both groups (Fig. 2 ). The ratio of ODC mRNA to GAPDH mRNA was 1.73 in Group 1 and 1.15 in control Group 2. Thus, the level was slightly, but not significantly, increased by NaHC03 plus AsA treatment.
Experiment 4
AsA concentrations in the urinary bladder epithelium were elevated in a dose-dependent manner (Fig. 3 ). This was significant for the 2 highest doses. SEM findings for the urinary bladder epithelial surface are summarized in Table VI . Ropy or leafy microridges were recognized on the luminal surface of urinary bladder epithelial cells after high-dose AsA treatment, especially in the 5% group. Short, uniform microvilli were also observed limited to the 5% group, albeit at relatively low frequency. These lesions were not seen in the 0 or 1 % low-dose groups, where peaked microridges indicating normal status were ubiquitous. Slight simple hyperplasia was noted for groups of the 2 highest doses under the light microscope. 2. -RNase protection assay of ODC mRNA from urinary bladder mucosa of rats treated with 5% AsA and 1.5% NaHC03 for 8 wk. C, control group; T, treatment group.
DISCUSSION
The present study confirmed copromotion potential for AsA and further demonstrated that the effects of this chemical are markedly dose dependent. In particular, the high-dose level of AsA amplified NaHC03 promotion of rat urinary bladder carcinogenesis. More importantly, in terms of the mechanism, the highest dose level clearly caused increased cell proliferation.
Fukushima et al (13) have conducted a series of investigations into promoting activities of various agents for urinary bladder carcinogenesis in male rats and have established sodium L-ascorbate (Na-AsA), the sodium ion form of AsA, to have strong promoting activity (14) . Numerous studies focusing on urinary contents revealed that urinary Na+, K+ concentrations and pH play important roles in promotion (8, 14, 15, 17, 19, 21-24, 36, 44, 45) . AsA itself was found to act as an amplifier, a so- Grading: -, no change; ±, slight change; +, moderate change; + +, severe change; ( ), number of rats in which the morphologic feature was observed. called copromoter, under certain conditions, such as increased urinary pH and sodium ion or potassium ion concentrations (15, 19, 21) . The results of the present study with equal sodium ion levels and alkaline urinary pH are thus in agreement with earlier findings. In addition, AsA copromoting actvity was exerted with dose-dependence of AsA contents in the urinary bladder epithelium.
Of great interest in this context is the fact that AsA concentrations in the urinary bladder epithelium were found to be significantly elevated in an AsA dose-dependent manner by administration of NaHC03 and AsA. This was earlier found to occur after treatment with Na-AsA or the synthetic antioxidant butylated hydroxyanisole (BHA) , which is also a urinary bladder cancer promoter in the rat (46) . Shibata et al (46) suggested that this phenomenon might be explained by stimulation of intracellular AsA synthesis or by sodium ion transport into the urinary bladder cells from the urine, i.e., movement of AsA was accompanied by sodium ions. The elevation might be attributed to such a mechanism. Sodium ions themselves alter the conditions of Na+/H+ exchange and activate Na+ influx, resulting in stimulation of DNA synthesis (27, 33, (37) (38) (39) (40) . Actually, it has been proven that increased intracellular sodium concentration and pH are associated with DNA synthesis and cell proliferation in vivo and in vitro (2, 4) . Combined administration of AsA and NaHC03 may yield both activation of ion exchange and elevation of intracellular AsA. The finding of the latter might therefore be regarded as conclusive evidence of copromotion of rat urinary bladder carcinogenesis.
In the present study, the areas of urinary bladder tumors measured by image analyzer were increased in line with the dose of AsA administered. Our results for carcinomas indicate that AsA plus NaHC03 act in both promotion and progression phases. Direct evidence of stimulation of cell proliferative activity was obtained from the BrdU incorporation study, demonstrating a loose dose dependence. Similar results in alterations of the urinary bladder surface, observed by SEM, are considered indicative of proliferation. As such, morphological findings have been recognized in reversible and irreversible hyperplasia of the urinary bladder epithelium (10-12, 20, 30, 41) ; the present SEM study provided clear evidence of hyperplasiogenic influence.
The polyamine synthetic enzyme ODC is known to be elevated by tumor promoters in various target organs (25, 50) and cells (52) . In the present study, neither its activity nor its mRNA level showed any significant increase in epithelial cells of urinary bladder given NaHC03 plus AsA for 8 wk. However, ODC mRNA level in papillomatosis, with severe epithelial proliferation induced by uracil treatment for 2 wks, was found to be only 2-fold higher than in normal epithelium, whereas the activity was increased about 40-fold (unpublished data). Further study is needed to determine the relevence of ODC to cell proliferation.
AsA has antioxidant activity and is thought to protect cells against DNA damage (34) , but inversely promotes production of oxygen free radicals in the presence of Fe3+ or Cuz+ (48) . Under these conditions, AsA is not likely to act as a tumor preventer. In this study, administration of NaHC03 plus AsA also did not act as an inhibitor but rather as a copromoter. Actually, this may be in line with the fact that BHA is generally accepted as a tumor promoter on rat urinary bladder and as a nongenotoxic carcinogen for the rat forestomach (28, 42, 43, 46) . Recently Cohen et al (7) hypothesized that a2u-globulin, which is synthesized in the male rat liver and excreted into the urine in large quantities, may be a necessary component for promotion of rat urinary bladder carcinogenesis. Indeed, it has been shown that NBR male rats that lack a2u-globulin-synthesizing ability do not demonstrate the expected increases in epithelial cell proliferation after sodium saccharin and Na-AsA treatment (26, 49) . Moreover, it has been suggested that crystals and precipitates in the urine contribute to promotion of urinary bladder carcinogenesis (9, 51) . Future studies on any quantitative correlation between these factors and the AsA dose are thus warranted.
